Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EpoRepair
NCT02076373Phase 3Unknown
- Sponsor
- University of Zurich
- Start
- Mar 2014
- Primary completion
- Dec 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 3 trial of erythropoietin in intraventricular hemorrhage of prematurity (IVH), hemorrhagic transformation of ischemic stroke (HT), sponsored by University of Zurich. Status: unknown.
02
Drugs
erythropoietin
03
Conditions
intraventricular hemorrhage of prematurity (IVH)hemorrhagic transformation of ischemic stroke (HT)
Beyond the preview
Go deeper on NCT02076373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02076373.